Mechanisms for pro matrix metalloproteinase activation

APMIS

Volumn 107, Issue 1, 1999, Pages 38-44

  Murphy, Gillian ^a   Stanton, Heather ^a   Cowell, Susan ^b   Butler, Georgina ^a   Knäuper, Vera ^a   Atkinson, Susan ^a   Gavrilovic, Jelena ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Activation; Matrix metalloproteinase; TIMP

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033002795     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01524.x     Document Type: Review

References (49)

1. 1. Mignatti P, Robbins E, Rifkin DE. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 1986;47:487-98.
2. 2. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 1992;667:1-12.
3. 3. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990;197:721-30.
4. 4. Knäuper V, Will H, López-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation - Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-31.
5. 5. Knäuper V, Smith B, López-Otin C, Murphy G. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 1997;248:369-73.
6. 6. Cowell S, Knäuper V, Stewart ML, d'Ortho MP, Stanton H, Hembry R, López-Otin C, Reynolds JJ, Murphy G. Induction of matrix metalloproteinase activation cascades based on membrane type I matrix metalloproteinase. Biochem J 1998;331:453-8.
7. 7. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51.
8. 8. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. Membrane-type matrix metalloproteinases 1 and 2 (MT1-and MT2-MMP) exhibit a broad spectrum proteolytic capacity comparable to many matrix metalloproteinases. Eur J Biochem 1997;250:751-7.
9. 9. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, Murphy G. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 1995;270:30479-85.
10. 10. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation - Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996;271:17119-23.
11. 11. Butler GS, Will H, Atkinson SJ, Murphy G. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem 1997;244:653-7.
12. 12. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJP. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 1992;283:637-41.
13. 13. Ward RV, Atkinson SJ, Reynolds JJ, Murphy G. Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem J 1994;304:263-9.
14. 14. Strongin AY, Marmer BL, Grant GA, Goldberg GI. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993;268:14033-9.
15. 15. Strongin AY, Collier I, Bannikov, G, Marmer BL, Grant GA, Goldberg, GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270:5331-8.
16. 16. Cao J, Sata H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation. J Biol Chem 1995;270:801-5.
17. 17. Sato H, Takino, T Kinoshita, T, Imai K, Okada Y, Stevenson WGS, Seiki M. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett 1996;385:238-40.
18. 18. Cao JA, Rehemtulla A, Bahou W, Zucker S. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J Biol Chem 1996;271:30174-80.
19. 19. Butler GS, Butler M., Atkinson SJ, Will H, Tamura T, Schade van Westrum S, Crabbe T, Clements J, d'Ortho M-P, Murphy G. The TIMP-2-membrane type I metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1997;273:871-80.
20. 20. Lee AY, Akers KT, Collier M, Li L, Eisen AZ, Seltzer JL. Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc Natl Acad Sci USA 1997;94:4424-9.
21. 21. Pendás AM, Knäuper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G, López-Otín C. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 1997;272:4281-6.
22. 22. Knäuper V, Cowell S, Smith B, López-Otin C, O'Shea M, Morris H, Zardi L, Murphy G. The role of the c-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997; 272: 7608-16.
23. 23. Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H, Nagataki S. TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 1996;89:553-7.
24. 24. Lohi J, Lehti K, Westermarck J, Kähäri VM, Keski-Oja J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 1996;239:239-47.
25. 25. Yang MZ, Hayashi K, Hayashi M, Fujii JT, Kurkinen M. Cloning and developmental expression of a membrane-type matrix metalloproteinase from chicken. J Biol Chem 1996;271:25548-54.
26. 26. Gilles C, Polette M, Seiki M, Birembaum P, Thompson EW. Implication of collagen type 1-induced membrane-type 1 matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest 1997;76:651-60.
27. 27. Yu M, Sato H, Seiki M, Thompson EW. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 1995;55:3272-7.
28. 28. Thant AA, Serbulea M, Kikkawa F, Liu E, Tomoda Y, Hamaguchi M. c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells. FEBS Lett 1997;406:28-30.
29. 29. Foda HD, George S, Conner C, Drews M, Tompkins DC, Zucker S. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab Invest 1996;74:538-45.
30. 30. Tomasek JJ, Halliday NL, Updike DL, Ahern-Moore JS Vu, TKH, Liu RW, Howard EW. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 1997;272:7482-7.
31. 31. Ailenberg M, Silverman M. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). Biochem J 1996;313:879-84.
32. 32. Lohi J, Keski-Oja J. Calcium ionophores decrease peri-cellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem 1995;270:17602-9.
33. 33. Yu M, Sato H, Seiki M, Spiegel S, Thompson EW. Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation. FEBS Lett 1997;412:568-72.
34. 34. Stanton H, Gavrilovic J, Atkinson SJ, d'Ortho M-P, Yanada K, Zardi L, Murphy G. The activation of pro MMP2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP14) to a 45 kDa form. J Cell Sci 1998; submitted.
35. 35. Yamada KM, Kennedy DW, Yamada SS, Gralnick H, Chen W-T, Akiyama SK. Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Res 1990;50:4485-96.
36. 36. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995;131:791-805.
37. 37. Kubota S, Ito H, Ishibashi Y, Seyama Y. Anti-alpha3 integrin antibody induces the activated form of matrix metalloproteinase-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int J Cancer 1997;70:106-11.
38. 38. Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJC. Role of the αvβ3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 1992;89:1557-61.
39. 39. Smeekens SP. Processing of protein precursors by a novel family of subtilisin-related mammalian endoproteases. BioTechnology 1993;11:182-6.
40. 40. Taylor JM. Transgenic rabbit models for the study of atherosclerosis. Ann NY Acad Sci 1997;811:146-54.
41. 41. Seidah N, Chrétien M. Eukaryotic protein processing: endoproteolysis of precursor proteins. Curr Opin Biotech 1997;8:602-7.
42. 42. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995;375:244-7.
43. 43. Pei DQ, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996;271:9135-40.
44. 44. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996;393:101-4.
45. 45. Okumura Y, Sato H, Seiki M, Kido H. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin - A possible cell surface activator. FEBS Lett 1997;402:181-4.
46. 46. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh YY, Chen WT. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 1997;94:7959-64.
47. 47. Cockett MI, Murphy G, Birch ML, O'Connel L, Crabbe T, Millican AT, Hart IR, Docherty ASP. Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp 1997;63:295-313.
48. 48. Sato H, Tanaka M, Takino T, Inoue M, Seiki M. Assignment of the human genes for membrane-type -1, -2 and -3 matrix metalloproteinases (MMP-14, MMP15 and MMP-16) to 14q12.2-16q12.2-q21 and 8q21 respectively by in situ hybridisation. Genomics 1997;39: 412-3.
49. 49. Deryugina EI, Bourdon MA, Luo G-X, Reisfeld RA, Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Science 1997;110:2473-82.